Search for Clinical Trial Results

Sponsored By

Proteus Infections - 11 Studies Found

Status Study
Enrolling by invitation Study Name: Dose Finding Trial of ARQ 092 in Children and Adults With Proteus Syndrome
Condition: Proteus Syndrome
Date: 2015-10-31
Interventions: Drug: ARQ 092
Recruiting Study Name: Study of Proteus Syndrome and Related Congenital Disorders
Condition:
  • Growth Disorder
  • Mental Retardation
  • Multiple Abnormalies Date: 1999-11-03
Withdrawn Study Name: Proteus Sustained Behavior Change Study
Condition: Type 2 Diabetes Mellitus
Date: 2011-12-28
Interventions:
  • Device: Proteus Sustained Behavior Change system

Completed Study Name: Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes
Condition:
  • Hypertension
  • Diabetes Mellitus, Type 2
  • Hypercholesterolemi
    Date: 2016-06-29
    Interventions:
    • Other: Proteus Discover FDA cl
Recruiting Study Name: Study of ARQ 092 in Patients With Overgrowth Diseases and Vascular Anomalies
Condition:
  • Proteus Syndrome
  • PIK3CA-Related Overgrowth Spectrum (PROS)

    • Date: 2017-03-17
    Interventions: Drug: ARQ 092 Subjects will receive ARQ 092 orally at the dose level and administration schedule specifi
Completed Study Name: Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Condition:
  • Infection
  • E Coli Infections
  • Klebsiella Infections
    • Date: 2006-08-10
Active, not recruiting Study Name: Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.
Condition: High Risk Proliferative Diabetic Retinopathy
Date: 2013-09-10
Interventions:
  • Procedure: Panretinal Photocoagulation (PRP)
Completed Study Name: Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
Condition:
  • Coronary Artery Disease
  • Proteus Syndrome
  • Detection Accuracy
  • Patient Compliance

Date: 2011-03-21
Interventions: Drug: ECMPS-IEM ECMPS-IEM
Next >>>